ArticleFrontiers in medicine2022

Xanthine Oxidoreductase Inhibitor Use Associated With Reduced Risk of Sarcopenia and Severe Sarcopenia in Patients Undergoing Hemodialysis.

Masafumi Kurajoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.